Janux Therapeutics, Inc.

Janux Therapeutics, Inc. financial statements

Janux Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueUSD 10M10-K
Net income−USD 113.63M10-K
Cash and equivalentsUSD 52.33M10-Q
Total debtUSD 22.14MEODHD

Janux Therapeutics, Inc. financials on 6ix · Janux Therapeutics, Inc. on 6ix